Articles by Angie Drakulich - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Angie Drakulich

A World without R&D

Will the next US President support the backbone of our industry?
Oct 2, 2012

Will the next US President support the backbone of our industry?

Despite Setbacks, PhRMA Awards Encourage Research into and Fight against Alzheimer's

Delaying the onset of AD by just five years could reduce the cost for care of Alzheimer's patients by $447 billion a year by 2050, according to a new PhRMA report.
Sep 13, 2012

Delaying the onset of Alzheimer's disease by just five years could reduce the cost for care of Alzheimer's patients by $447 billion a year by 2050, according to a new PhRMA report.

Just Announced: PhRMA's Research and Hope Award Recipients

The Pharmaceutical Research and Manufacturers of America has unveiled its 2012 Research and Hope Award recipients.
Sep 7, 2012

John Castellani, President of PhRMA, talks to PharmTech about its 2012 Research and Hope Award recipients.

PhRMA Research Awards Focus on Alzheimer's Disease

Aug 13, 2012

On Sept. 12, 2012, PhRMA is cohosting a brand new national awards program in Washington, DC, to honor individuals and organizations that have contributed significantly to the fight against Alzheimer's Disease.

The Truth About Drug Shortages

Manufacturers willing to report bad news about the supply can help reverse the shortage trend.
Aug 2, 2012

Manufacturers willing to report bad news about the supply can help reverse the shortage trend.

The Truth About Drug Shortages

Aug 1, 2012

Most of the products affected by growing drug and ingredient shortages are cancer medications, anesthetics used for patients undergoing surgery, emergency medications and intravenous electrolytes.

Bioavailability Enhancement: When to Use Hot-Melt Extrusion versus Spray Drying

Enhancing bioavailability can be achieved through hot-melt extrusion (HME) or spray drying. The drug product's API properties and stage of development are important factors to consider when deciding which technique to use. There are also considerations to be made with regard to process, time and cost. To gain perspective on these issues as well as insight into more recent advances in HME and spray drying, Pharmaceutical Technology Europe (PTE) spoke to Bend Research, an independent drug-formulation developm
Aug 1, 2012

Enhancing bioavailability can be achieved through hot-melt extrusion (HME) or spray drying.

Atypical Visible Particles

An industry roundtable on how users and makers can best assess and manage black specks.
Jul 2, 2012

An industry roundtable on how users and makers can best assess and manage black specks.

Pharmaceutical Technology: 35 Years and Going Strong

Taking time to appreciate the industry's greatest achievements will inspire growth ahead.
Jul 2, 2012

Taking time to appreciate the industry's greatest achievements will inspire growth ahead.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
8%
Protecting the supply chain
40%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here